Spyre Therapeutics, Inc. (SYRE)
92.91
+2.58
(+2.86%)
USD |
NASDAQ |
Oct 26, 16:00
92.81
-0.10
(-0.11%)
After-Hours: 20:00
Spyre Therapeutics Price to Book Value : 8.570 for Oct. 26, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 8.570 |
| October 23, 2026 | 8.332 |
| October 22, 2026 | 8.517 |
| October 21, 2026 | 8.574 |
| October 20, 2026 | 8.431 |
| October 19, 2026 | 7.815 |
| October 16, 2026 | 7.370 |
| October 15, 2026 | 7.388 |
| October 14, 2026 | 7.253 |
| October 13, 2026 | 7.421 |
| October 12, 2026 | 7.924 |
| October 09, 2026 | 7.904 |
| October 08, 2026 | 7.370 |
| October 07, 2026 | 7.458 |
| October 06, 2026 | 7.389 |
| October 05, 2026 | 8.553 |
| October 02, 2026 | 8.596 |
| October 01, 2026 | 8.295 |
| September 30, 2026 | 8.212 |
| September 29, 2026 | 7.815 |
| September 28, 2026 | 7.913 |
| September 25, 2026 | 7.904 |
| September 24, 2026 | 8.033 |
| September 23, 2026 | 8.133 |
| September 22, 2026 | 8.483 |
| Date | Value |
|---|---|
| September 21, 2026 | 8.489 |
| September 18, 2026 | 8.325 |
| September 17, 2026 | 8.549 |
| September 16, 2026 | 8.410 |
| September 15, 2026 | 8.389 |
| September 14, 2026 | 8.376 |
| September 11, 2026 | 8.357 |
| September 10, 2026 | 8.183 |
| September 09, 2026 | 8.018 |
| September 08, 2026 | 8.375 |
| September 04, 2026 | 8.208 |
| September 03, 2026 | 8.048 |
| September 02, 2026 | 8.030 |
| September 01, 2026 | 8.163 |
| August 31, 2026 | 8.240 |
| August 28, 2026 | 8.335 |
| August 27, 2026 | 8.635 |
| August 26, 2026 | 8.634 |
| August 25, 2026 | 9.903 |
| August 24, 2026 | 9.838 |
| August 21, 2026 | 9.823 |
| August 20, 2026 | 9.943 |
| August 19, 2026 | 10.05 |
| August 18, 2026 | 9.945 |
| August 17, 2026 | 9.648 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Incyte Corp. | 3.589 |
| SELLAS Life Sciences Group, Inc. | 16.63 |
| Relay Therapeutics, Inc. | 4.449 |
| ACADIA Pharmaceuticals, Inc. | 2.600 |
Price to Book Value Related Metrics
| Price | 92.91 |
| Earnings Yield | -2.35% |
| Market Cap | 8.182B |